一个偏向的全调节器作为分子剂起作用,诱导β2AR二元化
Jiemin Shen1,2, Teja Nikhil Peddada1,2, Konstantin E Komolov3,2
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
一种新型的小分子AP-7-168作为分子剂,促进β2-上腺素受体 (β2AR) 分解. 这种由连接体诱导的二分化稳定了受体,防止了β-arrestin合和偏向信号通路.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- G蛋白结合受体 (GPCRs),特别是A家族的GPCRs,通常被视为单体.
- 新出现的证据表明,GPCRs可以形成具有独特信号特性的二次体.
- 目前尚不完全了解GPCR二元化的机制和治疗含义.
研究的目的:
- 研究一种新型小分子AP-7-168在调节β2-上腺素受体 (β2AR) 功能的作用.
- 阐明AP-7-168诱导的β2AR二元化的结构基础和细胞后果.
- 探索联结体诱导的二分化作为GPCRs的治疗策略.
主要方法:
- 电子显微镜 (Cryo-EM) 用于确定β2AR二次体的结构.
- 细胞测试以评估β2AR二分化和纳米团形成.
- 功能性研究来评估信号偏差和全调制.
主要成果:
- AP-7-168作为一个分子剂,稳定β2AR同位体.
- 冷-EM结构显示AP-7-168结合在相邻原体的跨膜螺旋体3,4和5内.
- AP-7-168的结合阻止了β-arrestin的合,并促进了细胞中的β2AR纳米集群的形成.
- 该分子通过这种二元化机制选择性地偏向β2AR信号传输.
结论:
- 联体诱导的二分化是一种全性GPCR调节的新机制.
- AP-7-168提供了一种化学工具来探测和诱导β2AR二分化.
- 向GPCR二分化为涉及β2AR信号的疾病提供了一个有前途的治疗策略.
更多相关视频
相关概念视频
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Cooperative Allosteric Transitions
2.6K
2.6K
Cooperative Allosteric Transitions
3.0K
3.0K
Allosteric Regulation
62.8K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.8K
Ligand Binding and Linkage
5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K


